论文部分内容阅读
目的:观察鼻塞式持续气道正压通气(NCPAP)呼吸支持及琥珀酸氢化可的松静滴治疗小儿重症毛细支气管炎疗效。方法:将60例重症毛细支气管炎患儿随机分为对照组25例和治疗组35例,对照组仅予常规治疗,治疗组另予NCPAP呼吸支持及琥珀酸氢化可的松静滴。比较两组治疗前、后患儿临床表现改善情况。结果:治疗组和对照组的三凹征、喘息、喘鸣音、咳嗽的消失时间分别为0.3 d、0.8 d、1.5 d、4.3 d和1.1 d、2.2d、3.3 d和5.5 d;P均<0.05。结论:应用NCPAP呼吸支持及静滴琥珀酸氢化可的松治疗重症毛细支气管炎患儿较常规治疗的疗效好。
Objective: To observe the efficacy of nasal continuous positive airway pressure (NCPAP) and intravenous infusion of hydrocortisone succinate in children with severe bronchiolitis. Methods: Sixty children with severe bronchiolitis were randomly divided into control group (n = 25) and treatment group (n = 35). The control group was treated only routinely. The treatment group received NCPAP respiration support and hydrocortisone succinate infusion. The improvement of clinical manifestations in children before and after treatment was compared between the two groups. Results: The duration of disappearance of wheal, wheezing, wheezing and cough were 0.3 d, 0.8 d, 1.5 d, 4.3 d and 1.1 d, 2.2 d, 3.3 d and 5.5 d respectively in the treatment group and the control group. <0.05. Conclusion: NCPAP respiratory support and intravenous infusion of hydrocortisone succinate in patients with severe bronchiolitis are more effective than conventional therapies.